Senti Biosciences Inc logo

SNTI

HEALTHCARE

Senti Biosciences Inc

$0.97+0.02 (+1.82%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving SNTI Today?

No stock-specific AI insight has been generated for SNTI yet. Check back soon — insights are generated from recent news analysis.

52-Week Range

$0.77$3.88

$0.97

Fundamentals

Market Cap$31M
P/E Ratio
EPS$-2.73
Dividend Yield
Dividend / Share
ROE-2.2%
Profit Margin
Debt / Equity

Trading

Volume108K
Avg Volume (10D)
Shares Outstanding31.1M

SNTI News

20 articles

All 20 articles loaded

Price Data

Open$0.95
Previous Close$0.95
Day High$0.96
Day Low$0.95
52 Week High$3.88
52 Week Low$0.77

About Senti Biosciences Inc

Senti Biosciences Inc (SNTI) is an innovative biotechnology company at the forefront of synthetic biology, dedicated to pioneering next-generation cell and gene therapies. Utilizing its proprietary GeneCircuit platform, the company is developing programmable therapies aimed at treating a spectrum of diseases, including cancer and genetic disorders, thereby enhancing the precision of personalized medicine. With a robust development pipeline and strong strategic partnerships, Senti is strategically positioned to drive advancements in engineered cell therapies, offering transformative solutions to address critical unmet medical needs in the biopharmaceutical sector.

48 employees
Listed June 9, 2022
HEALTHCAREBIOTECHNOLOGY

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SICBIOTECHNOLOGY
CIK
Composite FIGI
Share Class FIGI